Baker McKenzie’s Sanctions Blog published the alert titled Switzerland Implements Further EU Sanctions Measures on 9 January 2023. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.
The Spanish government has modified, once again and with immediate effect from 28 December 2022, Spanish foreign direct investment rules that were introduced in March 2020 in connection with the COVID-19 pandemic.
Given the intensity and pace of change related to sanctions following the Russian invasion of Ukraine, EU Member…
Industrial action is on the rise throughout Europe; in this webinar we looked at the differences and similarities in the industrial action process across France, Germany, Italy, Spain, the Netherlands, Poland and the UK, the potential legal remedies in each jurisdiction and the practical steps employers can take to keep the business running.
The long-awaited implementation in statutory law of the fight against medical devices and in vitro diagnosis medical devices shortages mechanism is currently being discussed in the French Parliament, in a bill containing various provisions adapting French law to European Union law on diverse topics and particularly in the field of public health.
On 24 November 2022, the French Agency for the Safety of Medicines and Health Products issued three sentences against pharma companies that have failed to meet their reporting obligation regarding the risk of a medicinal products supply shortage or a supply shortage.
In brief This publication features the latest Employment developments in Italy. New laws and regulations Extension of the right to work remotely A new law recently extended, until 31 March 2023, the right of vulnerable employees to work in agile mode. However, the right to work remotely was not extended…
The German Bundestag passed the German Whistleblower Protection Act on 16 December 2022. After initially not being expected to be passed this year, the bill did make it onto the agenda of the last session day of the year at short notice and was passed in a version amended by the Legal Affairs Committee (Rechtsausschuss) with the coalition’s majority. The next step is for the Bundesrat to approve the bill. However, this is not expected until the first plenary session in February 2023 at the earliest.
On 10 November 2022, the National Coordination Centre for Ethics Committees published the updated versions of the ‘Contract for the performance of clinical trials on medicines’, the ‘Contract for the performance of independent clinical trials on medicines’ and the ‘Contract for the performance of clinical investigations on medical devices that are not CE marked or CE marked but used outside their intended use’.
On 1 December 2022, Implementing Regulation EU 2022/2347 on the reclassification of groups of certain active medical devices without an intended medical purpose, as listed in Annex XVI to Regulation EU 2017/745, was published in the Official Journal of the EU.